Check out your Company Bowl for anonymous work chats.
We recognize how critical the understanding and interpretation of sequencing data is in your #COVID19 research, so we’ve made the core SARS-CoV-2 apps in our SARS-CoV-2 NGS Data Toolkit permanently free! Read our latest blog post for additional information. #DRAGEN #Sequencing
Illumina continues to invest in COVID-19 research - Illumina® Informatics Blog
We are proud to announce that for the first time, we were named a Military Times Best for Vets Employer. Thank you to all our #veteran employees that continue to give back by serving as mentors, participating on career panels, and supporting our recruitment efforts to grow the veteran talent pool.
Best For Vets 2020: Employers
"Our third quarter performance reflects the strength of our business, the talent and dedication of our people, and the enduring value of our mission. Thank you to our customers, partners, and employees. It is a privilege to join you at the forefront of innovation as we collectively advance human health." – Francis deSouza, CEO.
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021
Our commitment to global pay equity, female leaders and support of the UN Women’s Empowerment Principles are just some of the ways we champion women, both in the workplace and in our communities. We're proud to see our hard work recognized by Forbes.
The World's Top Female-Friendly Companies
CTO, Alex Aravanis MD PhD, shares his perspective when it comes to innovation and setting strategy for a fast growing company. “We make big strategic bets, but we try to do it in a smart way. They’re big investments. They’re very farsighted things that could take many years to play out, but we think it’s the right fundamental direction.”
The innovation imperative: Lessons from high-growth companies
Today we announced an agreement with Israel’s Ministry of Health to implement whole-genome sequencing for critically-ill newborns. The Genetics Institute at Tel Aviv Sourasky Medical Center is leading the 2-year pilot program with the aim of accelerating diagnoses and improving care. #Sequencing #NGS
Press Release
Whole genome sequencing unlocks a wealth of knowledge. Find out how Illumina sequencing can benefit our most precious family members. #Genomics #Sequencing #NGS
Press Release
We are excited to announce Bob Ragusa's appointment as CEO of GRAIL, Inc.. Bob has worked in the genomics space for several decades and brings a strategic vision and strong track record of execution to help successfully scale GRAIL. Welcome Bob!
Press Release
We are excited to announce that our San Diego locations are now sourcing 100% renewable, clean energy as part of our efforts to reach our #NetZero by 2050 goal.
Illumina on LinkedIn: Illumina Commits to 100 Percent Clean, Renewable Energy from San Diego
We are proud to share that for the first time, Illumina has been included on Forbes' #WorldsBestEmployer List. The rankings are based on criteria including image, economic footprint, talent development, gender equality and social responsibility, and our recognition among the top 20 companies in our industry globally is a testament to our employees and our mission.
Illumina on LinkedIn: World's Best Employers 2021